- About Us
- Advertise
- Editorial
- Contact Us
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Pharmaceutical Commerce - September/October 2012
Solving the payer's problem: a new key to market access
August 30, 2012
Understand when total cost of care is the only winning argument - and when you can ignore it, says Oliver Wyman
Express Scripts and Walgreens settle, but now 'narrow networks' are in play
August 30, 2012
Implications for pharma are in continuing pricing pressure, and preferences for distribution channels
Owens & Minor plans to acquire Movianto Group, a European healthcare 3PL
August 30, 2012
Action adds to the increasing number of global healthcare-distribution pathways
Grappling with the long-term care market
August 30, 2012
The geriatric-dominated LTC market is growing, but has unique constraints
How cloud services accelerate market analytics
August 30, 2012
Deployment of Model N cloud-based IT services boosts internal capabilities at J&J
Making the EHR/e-prescribing/drug-label connection
August 30, 2012
Achieving a 'clinical workflow' compatible with doctors' and hospital administrators' online preferences is the goal; will pharma promotional messaging find a place?
Container selection and testing for safe drug product delivery
August 30, 2012
Elaborate testing is necessary to ensure the stability and functionality of today's drug-delivery systems
A conversation with Mike Alkire, Premier, Inc.
August 29, 2012
Premier, one of the leading group purchasing organizations (GPOs), is a vital linkage point between nearly 90,000 healthcare sites in the US, and the drug, device and hospital-supply vendors that serve them. Pharmaceutical Commerce sat down with Mike Alkire, chief operating officer of the company, to hear about what's driving GPO evolution today, and how it interacts with pharma manufacturers. Here's what he had to say:
Coordinating payer contracts and direct-to-patient discounting
August 29, 2012
Although controversial, patient-focused discounts can play a valuable role in managed-markets programs
Complex supply chains demand a holistic approach to protect patients
August 29, 2012
The USP standard, currently in draft form, is an effort to provide recommendations for end-to-end supply chain integrity
Tectonic shifts in the product-security debate
August 29, 2012
Industry is not waiting for action in Washington
Ensuring the quality of comparative effectiveness research
August 28, 2012
As payers seek higher-quality data from real-world treatment settings, the importance of reliable measures becomes critical
Integrated drug containment and delivery solutions
August 28, 2012
Design choices can make a difference in a crowded market
Building bridges to rare disease patients
August 28, 2012
Orphan drug development and marketing have important distinct requirements for R&D, regulatory and marketing
2012 Product Security Report
August 27, 2012
Serialization systems are going into operation around the world, but cross-industry collaboration awaits new legislation